{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:55:45Z","timestamp":1787702145667,"version":"build-2784847793"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>As a fatal disease, the mechanism of pancreatic cancer is unclear. Urothelial carcinoma antigen 1(UCA1), a long noncoding RNA (lncRNA) that was first reported in bladder cancer, acts as an oncogene. However, the regulatory role and mechanism of UCA1 in pancreatic cancer remain unknown. This study aims to investigate the expression level and prognostic value of UCA1 in pancreatic cancer tissues, the effects and mechanism of UCA1 in regulating cell proliferation, apoptosis and metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      UCA1 expression levels in tissues were detected by in situ hybridization (ISH) and the prognostic value was evaluated by univariate and multivariate survival analysis. For\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiments, proliferation was evaluated by a cell count kit assay, Edu experiments, and a clone formation assay. Apoptosis was evaluated by fluorescence-activated cell sorting flow-cytometry. Cell migration and invasion capacities were detected by wound healing and transwell assays. Western blots were performed to detect apoptotic associated molecules and epithelial-mesenchymal transition (EMT) markers. For the\n                      <jats:italic>in vivo<\/jats:italic>\n                      experiment, subcutaneous transplantation models of pancreatic cancer in nude mice were established to observe the tumor growth. The regulatory mechanism of UCA1 was explored by proteomics, bioinformatic analysis, luciferase reporter assays, and rescue experiments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ISH staining revealed that UCA1 levels between cancer tissues (n=94) and tumor-adjacent tissues (n=73) did not show significant differences. Survival analysis indicated that high expression of UCA1 was an unfavorable prognosis factor for pancreatic cancer. Downregulation of UCA1 by siRNA significantly inhibited cell proliferation, decreased the capacities of cell migration and invasion, induced cell apoptosis, and inhibited EMT. Furthermore, we demonstrated that UCA1 positively regulated the expression of BRCC3 by inhibiting miR-582-5p. Rescue experiments indicated that either inhibiting the expression of miR-582-5p or enhancing expression of BRCC3 could partly attenuate the antitumor effects of downregulation of UCA1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>UCA1 acted as an oncogene in pancreatic cancer by partly regulating miR-582-5p\/BRCC3, which could be a new therapeutic target for pancreatic cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2023.1133200","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T06:13:52Z","timestamp":1690265632000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["UCA1 executes an oncogenic role in pancreatic cancer by regulating miR-582-5p\/BRCC3"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaole","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA: Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13045-020-00958-3","article-title":"Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma","volume":"13","author":"Qian","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-021-09995-x","article-title":"Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer","volume":"40","author":"Sempere","year":"2021","journal-title":"Cancer Metastasis Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12935-020-1126-1","article-title":"The multifaceted roles of long noncoding RNAs in pancreatic cancer: an update on what we know","volume":"20","author":"Zhou","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2008.05.012","article-title":"UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion","volume":"582","author":"Wang","year":"2008","journal-title":"FEBS Lett"},{"key":"B6","doi-asserted-by":"publisher","first-page":"109459","DOI":"10.1016\/j.biopha.2019.109459","article-title":"UCA1 long non-coding RNA: An update on its roles in malignant behavior of cancers","volume":"120","author":"Ghafouri-Fard","year":"2019","journal-title":"Biomedicine pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5519720","DOI":"10.1155\/2021\/5519720","article-title":"Long noncoding RNA UCA1 in gastrointestinal cancers: molecular regulatory roles and patterns, mechanisms, and interactions","volume":"2021","author":"Ramli","year":"2021","journal-title":"J Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S200436","article-title":"The prognostic value and mechanisms of lncRNA UCA1 in human cancer","volume":"11","author":"Yao","year":"2019","journal-title":"Cancer Manage Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20211115","article-title":"Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer","volume":"41","author":"Wang","year":"2021","journal-title":"Bioscience Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2019.181233","article-title":"Function of long noncoding RNA UCA1 on gastric cancer cells and its clinicopathological significance in plasma","volume":"65","author":"Tang","year":"2019","journal-title":"Clin Lab"},{"key":"B11","first-page":"496","article-title":"The UCA1\/KRAS axis promotes human pancreatic ductal adenocarcinoma stem cell properties and tumor growth","volume":"9","author":"Liu","year":"2019","journal-title":"Am J Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1699","article-title":"LncRNA UCA1 impacts cell proliferation, invasion, and migration of pancreatic cancer through regulating miR-96\/FOXO3","volume":"70","author":"Zhou","year":"2018","journal-title":"IUBMB Life"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7150\/jca.79171","article-title":"The functional role of lncRNA UCA1 in pancreatic cancer: a mini-review","volume":"14","author":"Sun","year":"2023","journal-title":"J Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2184","article-title":"MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis","volume":"5","author":"Xu","year":"2014","journal-title":"Oncotarget"},{"key":"B15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13046-016-0406-z","article-title":"PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value","volume":"35","author":"Xu","year":"2016","journal-title":"J Exp Clin Cancer Res CR"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/15287394.2016.1176617","article-title":"lncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the Wnt signaling pathway","volume":"79","author":"Wang","year":"2016","journal-title":"J Toxicol Environ Health Part A"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.03.005","article-title":"LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway","volume":"1864","author":"Zhang","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2016.08.041","article-title":"Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer","volume":"83","author":"Chen","year":"2016","journal-title":"Biomedicine pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"B19","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s11596-019-2094-3","article-title":"Long noncoding RNA UCA1 overexpression is associated with poor prognosis in digestive system malignancies: A meta-analysis","volume":"39","author":"Shi","year":"2019","journal-title":"Curr Med Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27953","article-title":"Coexpression of UCA1 and ITGA2 in pancreatic cancer cells target the expression of miR-107 through focal adhesion pathway","volume":"234","author":"Gong","year":"2019","journal-title":"J Cell Physiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.720349","article-title":"BRCC3 promotes tumorigenesis of bladder cancer by activating the NF-\u03baB signaling pathway through targeting TRAF2","volume":"9","author":"Tao","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2543","article-title":"Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide","volume":"5","author":"Chai","year":"2014","journal-title":"Oncotarget"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.9511","article-title":"Knockdown of BRCC3 exerts an anti\u2212tumor effect on cervical cancer in vitro","volume":"18","author":"Zhang","year":"2018","journal-title":"Mol Med Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3892\/ijmm.19.1.29","article-title":"Expression of BRCC3, a novel cell cycle regulated molecule, is associated with increased phospho-ERK and cell proliferation","volume":"19","author":"Boudreau","year":"2007","journal-title":"Int J Mol Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15362","article-title":"Long noncoding RNA TMPO-AS1\/miR-126-5p\/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K\/Akt\/mTOR pathway","volume":"36","author":"Hu","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2012.11.009","article-title":"Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity","volume":"49","author":"Py","year":"2013","journal-title":"Mol Cell"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1133200\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T06:13:59Z","timestamp":1690265639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1133200\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":26,"alternative-id":["10.3389\/fonc.2023.1133200"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1133200","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,25]]},"article-number":"1133200"}}